Hypoxia: A key regulator of angiogenesis in cancer
Explore this paper's citation graph
Summary
The current understanding of hypoxia-induced tumor angiogenesis is covered and the caveats of hyp oxia-targeted antiangiogenic therapy for the treatment of cancer are discussed.
- Type
- review
- Published
- 2007-06-29
- Cited by
- 734
- References
- 89
- OpenAlex
- https://openalex.org/W1978506033
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:11740066
Keywords
Angiogenesis, Hypoxia (environmental), Regulator, HIF1A, Cancer research
References
- Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites.
- Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide.
- Mechanisms of angiogenesis and arteriogenesis
- Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
- Prolonged tumor dormancy by prevention of neovascularization in the vitreous.
- Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
- Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
- Critical role for NF‐κB‐induced JunB in VEGF regulation and tumor angiogenesis
- A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development.
- Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
- Age-Related Changes in Parathyroid Hormone-Related Protein and Vascular Endothelial Growth Factor in Human Osteoblastic Cells
- Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes.
- An essential role for p300/CBP in the cellular response to hypoxia.
- FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.
- A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
- Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression
- Tumor angiogenesis: therapeutic implications.
- Human Neural Stem Cells Over-Expressing VEGF Provide Neuroprotection, Angiogenesis and Functional Recovery in Mouse Stroke Model
- Induction of angiogenesis during the transition from hyperplasia to neoplasia
- Identification of MAPK Phosphorylation Sites and Their Role in the Localization and Activity of Hypoxia-inducible Factor-1α*
Cited by
- Correlative Imaging of Hypoxia and Angiogenesis in Oncology
- Rôle des facteurs de transcription E2F2 et ID3 dans la progression tumorale et intérêt du ciblage de l'aminopeptidase N/CD13 dans le traitement du cancer colique humain
- PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
- Transport of hypoxia-inducible factor HIF-1alpha into the nucleus involves importins 4 and 7.
- Novel monoclonal antibodies specific for CTLD-SSC and sialomucin domains of endosialin, a mural cell marker of tumor vasculature.
- Specific protein markers for stem cell cross-talk with neighboring cells in the environment.
- Cancer cells remodel themselves and vasculature to overcome the endothelial barrier
- Investigations into the Ulnar Response to Mechanical Stimuli Activating Lamellar and Woven Bone Formation
- Implication de l’Insulin-like Growth Factor (IGF-I), secrété par le microenvironnement tumoral, dans la survie et la chimiorésistance des cellules cancéreuses
- Mort cellulaire induite par des radiations ionisantes dans des tumeurs humaines radiorésistantes : étude, in vitro et in vivo, des mécanismes impliqués dans son induction par différents types de rayonnements et modulation pharmacologique
- The Hypoxic Tumor Microenvironment: A Driving Force for Breast Cancer Progression
- Mutationsanalyse und Charakterisierung von transkriptionellen Targetgenen des Metastasierungs-induzierenden Gens MACC1
- Rôle du treillis Mgat5/galectine-3 et de la cavéoline-1 dans la fibrillogenèse de la fibronectine et la migration cellulaire : Lien avec la dynamique des points focaux d'adhésion
- Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphoma
- BONE MARROW-DERIVED CELLS IN ANGIOGENESIS AND CANCER
- Investigation of the anti-breast cancer efficacy and mechanisms of disulfiram
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
- Hypoxia, therapeutic resistance, and sphingosine 1-phosphate.
- Vascular permeability—the essentials
- NADPH Oxidases as Regulators of Tumor Angiogenesis: Current and Emerging Concepts
Related papers
- Hypoxia-inducible factor 1 (HIF1A; HIF1); endothelial PAS domain protein 1 (EPAS1; HIF2A); hypoxia-inducible factor prolyl hydroxylase (EGLN2; HIF-PHD; EGLN)
- HIF1A employs CDK8-Mediator to stimulate RNAPII elongation
- von Hippel–Lindau tumor suppressor (VHL); hypoxia-inducible factor 1 (HIF1A; HIF1)
- Hypoxia-inducible factor prolyl hydroxylase (HIF-PH; EGLN); hypoxia-inducible factor 1α (HIF1A; HIF1α)
- Mouse model of von Hippel-Lindau renal cancer driven by hypoxia-inducible factor 1α (HIF1A; HIF1α)
- Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
- von Hippel-Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney Cancer
- Intermittent hypoxia enhances the expression of hypoxia inducible factor HIF1A through histone demethylation